Early surgery for superficial supratentorial spontaneous intracerebral hemorrhage: a Finnish Intensive Care Consortium study.
Intracerebral hemorrhage
Mortality
Neurosurgery
Outcome
Stroke
Surgery
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
28
04
2020
accepted:
18
06
2020
pubmed:
1
7
2020
medline:
16
3
2021
entrez:
1
7
2020
Statut:
ppublish
Résumé
The benefits of early surgery in cases of superficial supratentorial spontaneous intracerebral hemorrhage (ICH) are unclear. This study aimed to assess the association between early ICH surgery and outcome, as well as the cost-effectiveness of early ICH surgery. We conducted a retrospective, register-based multicenter study that included all patients who had been treated for supratentorial spontaneous ICH in four tertiary intensive care units in Finland between 2003 and 2013. To be included, patients needed to have experienced supratentorial ICHs that were 10-100 cm Of 254 patients, 27% were in the early surgery group. Overall 12-month mortality was 39%, while 29% survived without a permanent disability. According to our multivariable analysis, early ICH surgery was associated with lower 12-month mortality rates (odds ratio [OR] 0.22, 95% confidence intervals [CI] 0.10-0.51), but not with a higher probability of survival without permanent disability (OR 1.23, 95% CI 0.59-2.56). For the early surgical group, the ECPS and ECPIS were €111,409 and €334,227, respectively. For the non-surgical cohort, the ECPS and ECPIS were €76,074 and €141,471, respectively. Early surgery for superficial ICH is associated with a lower 12-month mortality risk but not with a higher probability of survival without a permanent disability. Further, costs were higher and cost-effectiveness was, thus, worse for the early surgical cohort.
Sections du résumé
BACKGROUND
The benefits of early surgery in cases of superficial supratentorial spontaneous intracerebral hemorrhage (ICH) are unclear. This study aimed to assess the association between early ICH surgery and outcome, as well as the cost-effectiveness of early ICH surgery.
METHODS
We conducted a retrospective, register-based multicenter study that included all patients who had been treated for supratentorial spontaneous ICH in four tertiary intensive care units in Finland between 2003 and 2013. To be included, patients needed to have experienced supratentorial ICHs that were 10-100 cm
RESULTS
Of 254 patients, 27% were in the early surgery group. Overall 12-month mortality was 39%, while 29% survived without a permanent disability. According to our multivariable analysis, early ICH surgery was associated with lower 12-month mortality rates (odds ratio [OR] 0.22, 95% confidence intervals [CI] 0.10-0.51), but not with a higher probability of survival without permanent disability (OR 1.23, 95% CI 0.59-2.56). For the early surgical group, the ECPS and ECPIS were €111,409 and €334,227, respectively. For the non-surgical cohort, the ECPS and ECPIS were €76,074 and €141,471, respectively.
CONCLUSIONS
Early surgery for superficial ICH is associated with a lower 12-month mortality risk but not with a higher probability of survival without a permanent disability. Further, costs were higher and cost-effectiveness was, thus, worse for the early surgical cohort.
Identifiants
pubmed: 32601805
doi: 10.1007/s00701-020-04470-y
pii: 10.1007/s00701-020-04470-y
pmc: PMC7593281
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
3153-3160Références
Lancet. 2013 Aug 3;382(9890):397-408
pubmed: 23726393
Crit Care. 2018 Sep 20;22(1):225
pubmed: 30236140
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
Stroke. 2015 Jul;46(7):2032-60
pubmed: 26022637
Stroke. 1999 Sep;30(9):1833-9
pubmed: 10471432
Stroke. 1993 Dec;24(12 Suppl):I115-7; discussion I118-9
pubmed: 8249006
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Lancet. 2005 Jan 29-Feb 4;365(9457):387-97
pubmed: 15680453
Stroke. 2019 Sep;50(9):2336-2343
pubmed: 31311464
Stroke. 1996 Aug;27(8):1304-5
pubmed: 8711791
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Stroke. 2012 Oct;43(10):2592-7
pubmed: 22858729
Crit Care Med. 2018 Apr;46(4):e302-e309
pubmed: 29293155
Resuscitation. 2018 Oct;131:128-134
pubmed: 29958958
Value Health. 2009 Mar;12 Suppl 1:S5-9
pubmed: 19250132
Clin Neurol Neurosurg. 2013 Aug;115(8):1350-5
pubmed: 23333004
Stroke. 1998 Dec;29(12):2580-6
pubmed: 9836771
Pharmacoeconomics. 2008;26(9):733-44
pubmed: 18767894
Stroke. 2012 Jun;43(6):1496-504
pubmed: 22511006
Acta Anaesthesiol Scand. 2012 Oct;56(9):1114-22
pubmed: 22384799
Int J Stroke. 2014 Oct;9(7):840-55
pubmed: 25156220
Lancet Neurol. 2010 Feb;9(2):167-76
pubmed: 20056489
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944